SFC

Sommaire


CARDIOLOGIE PÉDIATRIQUE

CARDIO-ONCOLOGIE

  • 📌 ​À LA UNE : Incidence of Immune Checkpoint Inhibitor–Induced Myocarditis During the COVID‐19 Pandemic | Lire l’article JAHA
  • Cardiac Magnetic Resonance to Predict Cardiac Mass Malignancy: The CMR Mass Score | Lire l’article Circulation
  • Potential Multidisciplinary Use of Large Language Models for Addressing Queries in Cardio‐Oncology | Lire l’article JAHA

CORONAIRES ET INTERVENTIONNEL

HTA

IMAGERIE CARDIOVASCULAIRE

INSUFFISANCE CARDIAQUE ET CARDIOMYOPATHIES

  • 📌 ​À LA UNE : Rethinking the Nomenclature of Heart Failure Cardiogenic Need to Start De Novo? | Lire l’article Circulation
  • Atrial Septal Defect, Pulmonary Arterial Hypertension, and Diastolic Left Heart Failure: When 3 Players Come into the Game | Lire l’article Circulation
  • Sacubitril/Valsartan in Patients Hospitalized With Decompensated Heart Failure | Lire l’article JACC
  • Virus-Induced Acute Respiratory Distress Syndrome Causes Cardiomyopathy Through Eliciting Inflammatory Responses in the Heart | Lire l’article Circulation

RISQUE CARDIOVASCULAIRE

  • 📌 ​À LA UNE : Mechanisms of Vascular Inflammation and Potential Therapeutic A Position Paper From the ESH Working Group on Small Arteries | Lire l’article Hypertension
  • Frailty and Cognitive Function in Middle-Aged and Older Adults With Congenital Heart Disease | Lire l’article JACC

RYTHMOLOGIE

  • 📌 ​À LA UNE : Risk of Malignant Ventricular Arrhythmias in Patients with Mild to Moderately Reduced Ejection Fraction Following Permanent Pacemaker Implantation | Lire l’article Heart Rhythm
  • Ablation of accessory pathways in different anatomical locations using focal pulsed field ablation | Lire l’article Heart Rhythm
  • Artificial intelligence predicts undiagnosed atrial fibrillation in patients with embolic stroke of undetermined source using sinus rhythm electrocardiograms | Lire l’article Heart Rhythm
  • Association between sodium-glucose cotransporter-2 inhibitors and arrhythmic outcomes in patients with diabetes and pre-existing atrial fibrillation | Lire l’article EP Europace
  • Early ablation of newly diagnosed paroxysmal atrial fibrillation (NEWPaAF) versus newly diagnosed persistent atrial fibrillation (NEWPeAF): Comparison of patient populations and ablation outcomes | Lire l’article Journal of Cardiovascular Electrophysiology
  • Genetic Factors Altering Immune Responses in Atrial Fibrillation: JACC Review Topic of the Week | Lire l’article JACC
  • Strategies to improve atrioventricular synchrony in patients with a Micra AV leadless pacemaker | Lire l’article EP Europace

USIC

  • 📌 ​À LA UNE : Transcatheter aortic valve replacement in patients with cardiogenic shock: safe and effective, but the most critical patients require further investigations | Lire l’article European Heart Journal
  • Diagnosis and treatment of right ventricular failure secondary to acutely increased right ventricular afterload (acute cor pulmonale): a clinical consensus statement of the Association for Acute CardioVascular Care of the European Society of Cardiology | Lire l’article European Heart Journal
  • Discovery of plasma proteins associated with ventricular fibrillation during first ST-elevation myocardial infarction via proteomics | Lire l’article European Heart Journal
  • Early predictors of clinical deterioration in intermediate-high risk pulmonary embolism: clinical needs, research imperatives, and pathways forward | Lire l’article European Heart Journal
  • Impella device in fulminant myocarditis: Japanese Registry for Percutaneous Ventricular Assist Device (J-PVAD) registry analysis on outcomes and adverse events | Lire l’article European Heart Journal

VALVULOPATHIES

DEEP LEARNING ET INTELLIGENCE ARTIFICIELLE

COVID

LA FRANCE À L’HONNEUR

Nos suggestions d’actualités

Les actualités Cardio Online

La muvalaplin : nouvel inhibiteur de la lp(a) par voie orale

21 novembre 2024

Pas de supériorité d’un système d’aide à la décision pour optimiser les thérapies hypolipémiantes dans le post SCA

21 novembre 2024

Efficacité et sécurité d’emploi de l’obicetrapib, un nouvel inhibiteur de la CETP

21 novembre 2024

Zerlasiran, encore un nouvel antiLp(a) en développement

21 novembre 2024

L’edoxaban pour la prévention de thrombose valvulaire

20 novembre 2024

24/11/2024
Actualités Congrès
Congrès

Les JESFC 2025 par le Groupe Rythmologie - Stimulation cardiaque

24/11/2024
Actualités Congrès
Congrès

JESFC 2025 : Ne manquez pas la conférence européenne !

22/11/2024
Actualités SFC
Veille bibliographique

La SFC a lu pour vous : Veille bibliographique - 22/11/24